Davison A - Search Results

1

Interspecies variation in biodistribution of technetium (2-carbomethoxy-2-isocyanopropane)6+.

Kronauge JF, Noska MA, Davison A, Holman BL, Jones AG. Kronauge JF, et al. Among authors: davison a. J Nucl Med. 1992 Jul;33(7):1357-65. J Nucl Med. 1992. PMID: 1613578 Free article.

2

Human pharmacokinetics and radiopharmacological studies of the myocardial perfusion agent: technetium (2-carbomethoxy-2-isocyano-propane)6+.

Kronauge JF, Leòn AS, Verdera ES, Balter HS, Leòn ET, Mut F, Oliveira MC, Garcia FA, Holman BL, Davison A, et al. Kronauge JF, et al. Among authors: davison a. J Nucl Med. 1992 Nov;33(11):1949-57. J Nucl Med. 1992. PMID: 1432155 Free article.

3

Comparison of neutral and cationic myocardial perfusion agents: characteristics of accumulation in cultured cells.

Kronauge JF, Chiu ML, Cone JS, Davison A, Holman BL, Jones AG, Piwnica-Worms D. Kronauge JF, et al. Among authors: davison a. Int J Rad Appl Instrum B. 1992 Feb;19(2):141-8. doi: 10.1016/0883-2897(92)90001-f. Int J Rad Appl Instrum B. 1992. PMID: 1601667

4

Comparative myocardial uptake characteristics of hexakis (alkylisonitrile) technetium(I) complexes. Effect of lipophilicity.

Piwnica-Worms D, Kronauge JF, Holman BL, Davison A, Jones AG. Piwnica-Worms D, et al. Among authors: davison a. Invest Radiol. 1989 Jan;24(1):25-9. doi: 10.1097/00004424-198901000-00007. Invest Radiol. 1989. PMID: 2917819

5

Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells.

Piwnica-Worms D, Kronauge JF, Holman BL, Lister-James J, Davison A, Jones AG. Piwnica-Worms D, et al. Among authors: davison a. J Nucl Med. 1988 Jan;29(1):55-61. J Nucl Med. 1988. PMID: 3335928 Free article.

6

The utilization of technetium-99m CPI as a myocardial perfusion imaging agent in exercise studies.

Sia ST, Holman BL, Campbell S, Lister-James J, English RJ, Kronauge JF, Davison A, Jones AG. Sia ST, et al. Among authors: davison a. Clin Nucl Med. 1987 Sep;12(9):681-7. doi: 10.1097/00003072-198709000-00001. Clin Nucl Med. 1987. PMID: 3665310

7

Effect of reperfusion and hyperemia on the myocardial distribution of technetium-99m t-butylisonitrile.

Holman BL, Campbell CA, Lister-James J, Jones AG, Davison A, Kloner RA. Holman BL, et al. Among authors: davison a. J Nucl Med. 1986 Jul;27(7):1172-7. J Nucl Med. 1986. PMID: 3755164 Free article.

8

Myocardial imaging with technetium-99m CPI: initial experience in the human.

Holman BL, Sporn V, Jones AG, Sia ST, Perez-Balino N, Davison A, Lister-James J, Kronauge JF, Mitta AE, Camin LL, et al. Holman BL, et al. Among authors: davison a. J Nucl Med. 1987 Jan;28(1):13-8. J Nucl Med. 1987. PMID: 3794805 Free article.

9

A new Tc-99m-labeled myocardial imaging agent, hexakis(t-butylisonitrile)-technetium(I) [Tc-99m TBI]: initial experience in the human.

Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, Tumeh SS, English RJ. Holman BL, et al. Among authors: davison a. J Nucl Med. 1984 Dec;25(12):1350-5. J Nucl Med. 1984. PMID: 6334145 Free article.

10

In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+.

Barbarics E, Kronauge JF, Costello CE, Jànoki GA, Holman BL, Davison A, Jones AG. Barbarics E, et al. Among authors: davison a. Nucl Med Biol. 1994 May;21(4):583-91. doi: 10.1016/0969-8051(94)90023-x. Nucl Med Biol. 1994. PMID: 9234315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,271 results

Search Page

Filters